首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 醫療設備 > 針對美國・歐洲泌尿科醫生的前列腺癌治療動向調查
產業/市場分類
醫療設備 (4528)
內視鏡檢查設備 (158)
分子呈像/呈影劑 (28)
心血管設備 (335)
可拋式醫學設備 (76)
核子醫學 (80)
病患監測 (382)
眼科設備 (102)
傷口護理 (159)
超音波 (54)
齒科設備 (174)
導管 (232)
整形外科 (335)
醫學影像診斷 (414)
體外診斷設備 (476)
CT/MRI/X光 (172)
e保健 (321)
市場調查報告書

針對美國・歐洲泌尿科醫生的前列腺癌治療動向調查

US and European Urologist Survey: Prostate Cancer Treatment Trends 2008

出版商 Millennium Research Group
出版日期 2008年06月 商品編碼 73852
內容資訊 英文  
價格
US $ 4197 PDF by E-mail (Single user license)
US $ 6300 PDF by E-mail (Corporate license)


針對美國・歐洲泌尿科醫生的前列腺癌治療動向調查 是由出版商Millennium Research Group在2008年06月所出版的。 這份英文市場調查報告書價格從美金4197起跳。

簡介

本報告書內容包括:以美國・歐洲泌尿器科醫生為調查對象的前列腺癌治療調查結果、醫生資歷、利用設備、各種前列腺癌治療的認知、利用、今後的導入計畫、對新治療法的認識等。內容綱要摘記如下:

調查内容

  • 工作地點
  • 利用設備資訊
  • 工作年資
  • 各種前列腺癌治療相關評析
    • 化學療法
    • 凍結外科手術
    • HIFU
    • 荷爾蒙治療
    • 放射線治療
    • 根治的前列腺切除術
    • 其他
  • 各種前列腺癌治療的普及
    • 化學療法
    • 凍結外科手術
    • 高線量(HDR)組織内照射治療
    • HIFU
    • 荷爾蒙治療
    • 間質近距離照射治療
    • 放射線治療(EBRT或IMRT)
    • 根治的前列腺切除術
    • 過程觀察
    • 其他
  • 各種前列腺癌治療今後的導入計畫
    • 化學療法
    • 冷凍外科手術
    • 高線量(HDR)組織内照射治療
    • HIFU
    • 荷爾蒙治療
    • 間質近距離照射治療
    • 放射線治療(EBRT或IMRT)
    • 根治的前列腺切除術
    • 過程觀察
    • 其他
  • 新治療方法的認識
    • 自我免疫治療
    • 基因治療
    • HIFU
    • 前列腺經會陰部的微波燒灼術(TAP)
    • 其他

目錄

Abstract

The majority of US and European respondents indicate that the following prostate cancer treatments are used at an appropriate rate: chemotherapy, hormone therapy, radiation therapy, and radical prostatectomy.

Table of Contents

Survey Questions

Geographical Stratification

  • Please identify where you currently practice.

Facility Information

  • Question: Which of the following best describes your facility?
    • »Teaching hospital, nonteaching hospital, small group practice, large group practice, solo practice, ambulatory service center (ASC)

Respondent Information

  • Question: How many years have you been in practice (post residency/fellowship)?
  • Question: Please identify the average age of your patients.

Insights on Prostate Cancer Treatment Options

  • Question: In general, how do you feel about the current rate of use for each of these prostate cancer treatments?
    • »Chemotherapy, cryosurgery, HIFU, hormone therapy, radiation therapy, radical prostatectomy, other
    • »Overused, underused, used at an appropriate rate, no opinion
  • Question: Of the underused prostate cancer treatments, which of the following barriers is the most significant to impending greater adoption?
    • »Concerned about liability, insufficient quality of life data, insufficientpatient outcomedata, insufficient reimbursement, limitedsupport from company or sales representative, must refer patients to other physician outside my practice, prefer other procedures that provide comparable outcomes, prefer other procedures that provide comparable quality of life

Penetration of Prostate Cancer Treatment Options

  • Question: Which of these treatment options do you currently use or refer prostate cancer patients for?
    • Please select all that apply.
      • »Chemotherapy, cryosurgery, high dose rate (HDR) brachytherapy, HIFU, hormone therapy, interstitial brachytherapy, radiation therapy (EBRT or IMRT), radical prostatectomy, watchful waiting, other
  • Question: Please indicate changes in your treatment frequency over the past year for each treatment option you currently
    • use or refer prostate cancer patients for.
      • »Significantly decreased, decreased, no change, increased, significantly increased
  • Question: Of your patients who are treated with interstitial brachytherapy, what percentage (%) received the following seeds?
    • Also, please indicate changes in treatment frequency over the past year.
      • »I - 125 seed, Pd - 103 seed, Cs - 137 seed
      • »Significantly decreased, decreased, no change, increased, significantly increased

Future Adoption of Treatment Options

  • Question: Of the treatment options that you do not currently useor refer patients for, which do you plan on adopting in the future? Please select all that apply.
    • »Chemotherapy, cryosurgery, high dose rate (HDR) brachytherapy, HIFU, hormone therapy, interstitial brachytherapy, radiation therapy (EBRT or IMRT), radical prostatectomy, watchful waiting, other
  • Question: When do you think you will adopt each treatment?
    • »Within 1 year, within 1 - 2 years, in more than 2 years
  • Question: Why are you planning to adopt each treatment?
    • »Better reimbursement, fewer post - procedural complications, shorter post - procedure recovery period than alternatives, superior clinical results, training provided by companies

Awareness of New Treatment Options

  • Question: Are you aware of any of the following new treatments, or treatments in development, for patients who suffer from prostate cancer? (Please select all that apply).
    • »Autoimmune therapy, gene therapy, HIFU, transperineal microwave ablation of the prostate (TAP), other
  • Question: How do you think the new treatments will impact the way patients who suffer from prostate cancer are treated?
    • »This will decrease the cost of treating a patient, this will decrease patient recovery times, this will improve patient outcomes, this will increase the number of patients eligible for treatment, this will make treatments more accessible to patients
Back to Top